Literature DB >> 16182933

Cerebrospinal fluid levels of neurofilament light in chronic experimental autoimmune encephalomyelitis.

N Norgren1, A Edelstam, T Stigbrand.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) induced by myelin oligodendrocyte glycoprotein (MOG) is a chronic relapsing-remitting animal model of multiple sclerosis (MS). Neurofilament light (NF-L), a structural protein expressed in neuronal cells can be used to quantify the amount of neuronal damage in MS patients. An immunoassay was used to measure levels of neurofilament light in cerebrospinal fluid (CSF) in rats with myelin oligodendrocyte glycoprotein-induced EAE. Significantly increased levels of neurofilament were found in the immunized animals compared to the controls, strengthening the similarities in the diseases and the progression pattern between the animal model and MS. The turnover of NF-L during this disease is increased since significantly elevated levels also were identified in the spinal cord of the diseased animals and immunohistochemistry gave support for this observation. Monitoring neurofilament levels in EAE can be used to follow disease progression and effects of therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182933     DOI: 10.1016/j.brainresbull.2005.06.031

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  5 in total

1.  Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE.

Authors:  Marloes van Zwam; Ruth Huizinga; Marie-José Melief; Annet F Wierenga-Wolf; Marjan van Meurs; Jane S Voerman; Knut P H Biber; Hendrikus W G M Boddeke; Uta E Höpken; Christian Meisel; Andreas Meisel; Ingo Bechmann; Rogier Q Hintzen; Bert A 't Hart; Sandra Amor; Jon D Laman; Leonie A Boven
Journal:  J Mol Med (Berl)       Date:  2008-12-03       Impact factor: 4.599

2.  Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.

Authors:  Johanna Gaiottino; Niklas Norgren; Ruth Dobson; Joanne Topping; Ahuva Nissim; Andrea Malaspina; Jonathan P Bestwick; Andreas U Monsch; Axel Regeniter; Raija L Lindberg; Ludwig Kappos; David Leppert; Axel Petzold; Gavin Giovannoni; Jens Kuhle
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

3.  Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.

Authors:  Joshua N Douglas; Lidia A Gardner; Hannah E Salapa; Stephen J Lalor; Sangmin Lee; Benjamin M Segal; Paul E Sawchenko; Michael C Levin
Journal:  J Neuroinflammation       Date:  2016-07-08       Impact factor: 8.322

4.  Diagnostic performance of new and classic CSF biomarkers in age-related dementias.

Authors:  Giuseppe Pelliccioni; Fabiola Olivieri; Francesca Marchegiani; Giulia Matacchione; Deborah Ramini; Fiorella Marcheselli; Rina Recchioni; Tiziana Casoli; Elisa Mercuri; Marco Lazzarini; Belinda Giorgetti; Valentina Cameriere; Susy Paolini; Lucia Paciaroni; Tommaso Rossi; Roberta Galeazzi; Rosamaria Lisa; Anna Rita Bonfigli; Antonio Domenico Procopio; Maria De Luca
Journal:  Aging (Albany NY)       Date:  2019-04-27       Impact factor: 5.682

5.  New CSF biomarkers on the block.

Authors:  Charlotte E Teunissen; Lucilla Parnetti
Journal:  EMBO Mol Med       Date:  2016-10-04       Impact factor: 12.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.